Cargando…
Sub-region based radiomics analysis for survival prediction in oesophageal tumours treated by definitive concurrent chemoradiotherapy
BACKGROUND: Evaluating clinical outcome prior to concurrent chemoradiotherapy remains challenging for oesophageal squamous cell carcinoma (OSCC) as traditional prognostic markers are assessed at the completion of treatment. Herein, we investigated the potential of using sub-region radiomics as a nov...
Autores principales: | Xie, Congying, Yang, Pengfei, Zhang, Xuebang, Xu, Lei, Wang, Xiaoju, Li, Xiadong, Zhang, Luhan, Xie, Ruifei, Yang, Ling, Jing, Zhao, Zhang, Hongfang, Ding, Lingyu, Kuang, Yu, Niu, Tianye, Wu, Shixiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6606893/ https://www.ncbi.nlm.nih.gov/pubmed/31129097 http://dx.doi.org/10.1016/j.ebiom.2019.05.023 |
Ejemplares similares
-
T4/N2 classification nasopharyngeal carcinoma benefit from concurrent chemotherapy in the era of intensity-modulated radiotherapy
por: Xie, Ruifei, et al.
Publicado: (2016) -
Long‐term results of definitive concurrent chemoradiotherapy using paclitaxel plus oxaliplatin in unresectable locally advanced esophageal cancer: a prospective phase II trial
por: Song, Tao, et al.
Publicado: (2016) -
Concurrent chemoradiotherapy using paclitaxel plus cisplatin in the treatment of elderly patients with esophageal cancer
por: Song, Tao, et al.
Publicado: (2015) -
Long‐term outcome of concurrent chemoradiotherapy with elective nodal irradiation for inoperable esophageal cancer
por: Jing, Zhao, et al.
Publicado: (2017) -
Chemoradiotherapy with extended nodal irradiation and/or erlotinib in locally advanced oesophageal squamous cell cancer: long-term update of a randomised phase 3 trial
por: Xie, Congying, et al.
Publicado: (2020)